Inspire Medical Systems Analyst Ratings
Inspire Medical Systems (INSP) Gets a Hold From Oppenheimer
Analysts' Top Healthcare Picks: Inspire Medical Systems (INSP), Cencora (COR)
Buy Rating Affirmed for Inspire Medical Systems Amid Robust Overseas Sales and Upbeat Full-Year Guidance
Inspire Medical Systems: Strong Growth and Positive Outlook Justify a Buy Rating
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)
Inspire Medical Systems Analyst Ratings
Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255
Piper Sandler Sticks to Its Buy Rating for Inspire Medical Systems (INSP)
RBC Capital Reaffirms Their Buy Rating on Inspire Medical Systems (INSP)
Inspire Medical Systems: Hold Rating Amidst Slowing Growth and Profitability Concerns
Inspire Medical Systems: A Balanced Hold Rating Amid Mixed Performance and Positive Outlook
KeyBanc Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)
Inspire Medical Systems (INSP.US) was first covered by the Royal Bank of Canada, which gave it an superior market rating, with a target price of $285.00.
Inspire Medical Systems Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI)
Analysts' Top Healthcare Picks: Inspire Medical Systems (INSP), Eli Lilly & Co (LLY)
Inspire Medical Systems: Assessing the Impact of Tirzepatide on Implant Sales and Maintaining a Hold Rating
Positive SURMOUNT-OSA Trial Results Reinforce Buy Rating for Inspire Medical Systems
No Data